[1] Li ZJ, Chen QL, Feng LZ, Rodewald L, Xia YY, Yu HL, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet 2020;396(10243):63 − 70. http://dx.doi.org/10.1016/S0140-6736(20)31278-2CrossRef
[2] Zhou L, Wu ZY, Li ZJ, Zhang YP, McGoogan JM, Li Q, et al. One hundred days of coronavirus disease 2019 prevention and control in China. Clin Infect Dis 2020;72(2):332 − 9. http://dx.doi.org/10.1093/cid/ciaa725CrossRef
[3] Li ZJ, Gao GF. Strengthening public health at the community-level in China. Lancet Public Health 2020;5(12):E629 − 30. http://dx.doi.org/10.1016/S2468-2667(20)30266-8CrossRef
[4] Eysenbach G. Infodemiology: the epidemiology of (mis)information. Am J Med 2002;113(9):763 − 5. http://dx.doi.org/10.1016/s0002-9343(02)01473-0CrossRef
[5] Su S, Wong G, Shi WF, Liu J, Lai ACK, Zhou JY, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24(6):490 − 502. http://dx.doi.org/10.1016/j.tim.2016.03.003CrossRef
[6] Gao GF. From “A”IV to “Z”IKV: attacks from emerging and re-emerging pathogens. Cell 2018;172(6):1157 − 9. http://dx.doi.org/10.1016/j.cell.2018.02.025CrossRef
[7] Wakefield A. A statement by Dr Andrew Wakefield. Lancet 2004;363(9411):823 − 4. http://dx.doi.org/10.1016/S0140-6736(04)15710-3CrossRef
[8] Gao GF, Nkengasong JN. Public health priorities for China–Africa cooperation. Lancet Public Health 2019;4(4):e177 − 8. http://dx.doi.org/10.1016/S2468-2667(19)30037-4CrossRef